Skip to main content

Advertisement

SpringerLink
Log in

Modern view on the diagnostics and treatment of adenomyosis

  • General Gynecology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Adenomyosis is identified by the enlargement of the uterus secondary to such areas of the endometrium as the endometrial glands and stroma located deep in the myometrium, which causes its hyperplasia and hypertrophy. The most common signs of the development of adenomyosis in a patient are copious menstrual bleeding and dysmenorrhea. However, it should be borne in mind that in some patients, the disease may be asymptomatic. Despite the wide abundance of imaging and other diagnostic methods for diagnosing adenomyosis, there are currently no standard verified diagnostic criteria for pathologists. In addition, women with adenomyosis often have other concomitant gynaecological diseases, such as endometriosis or leiomyomas, which makes it difficult to diagnose and choose the optimal treatment for patients. Therefore, the purpose of this study was to highlight up-to-date and relevant information for the practitioner about the epidemiology, clinical manifestations, diagnostics and treatment options for adenomyosis. Sources from four databases (PubMed, Web of Science, Elsevier and Google Scholar) were used to search for data. As a result of a literature review, it was established that the “gold” standard for the diagnostics of adenomyosis is histological research methods, in particular, biopsy performed during hysteroscopy or laparoscopy, whereas imaging methods (transvaginal sonography, magnetic resonance imaging) are more often used for differential diagnostics of adenomyosis with other diseases. In addition, magnetic resonance imaging allows for a better differential diagnostics between adenomyosis and myomatosis and helps to recognise the disease at an early stage. Regarding treatment, there is currently no particular therapy and algorithms for the treatment of adenomyosis, which is primarily due to the lack of precise criteria for the diagnostics of the disease. However, the most effective therapeutic methods at the present stage are the use of aromatase inhibitors and gonadotropin-releasing hormone antagonists, whilst minimally invasive techniques, in particular, endometrial ablation and uterine artery embolisation, are becoming increasingly popular amongst surgical techniques.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Data availability statement

The data that support the findings of this study are available on request from the corresponding author.

References

  1. Zhai J, Vannuccini S, Petraglia F, Giudice LC (2020) Adenomyosis: mechanisms and pathogenesis. Semin Reprod Med 38(2–03):129–143

    CAS  PubMed  PubMed Central  Google Scholar 

  2. García-Solares J, Donnez J, Donnez O, Dolmans M-M (2018) Pathogenesis of uterine adenomyosis: invagination or metaplasia? Fertil Steril 109:371–379

    Article  PubMed  Google Scholar 

  3. Vigano P, Candiani M, Monno A, Giacomini E, Vercellini P, Somigliana E (2018) Time to redefine endometriosis including its pro-fibrotic nature. Hum Reprod 33:347–352

    Article  CAS  PubMed  Google Scholar 

  4. Koninckx PR, Ussia A, Adamyan L, Tahlak M, Keckstein J, Wattiez A, Martin DC (2021) The epidemiology of endometriosis is poorly known as the pathophysiology and diagnosis are unclear. Best Practice Res Clin Obstetr Gynaecol 71:14–26

    Article  Google Scholar 

  5. Levgur M, Abadi MA, Tucker A (2000) Adenomyosis: symptoms, histology, and pregnancy terminations. Obstet Gynecol 95(5):688–691

    CAS  PubMed  Google Scholar 

  6. Upson K, Missmer SA (2020) Epidemiology of denomyosis. Semin Reprod Med 38(2–03):89–107

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Miyagawa C, Murakami K, Tobiume T, Nonogaki T, Matsumura N (2021) Characterization of patients that can continue conservative treatment for adenomyosis. BMC Women’s Health 21(1):431

    Article  PubMed  PubMed Central  Google Scholar 

  8. Deblaere L, Froyman W, van den Bosch T, van Rompuy AS, Kaijser J, Deprest J, Timmerman D (2019) Juvenile cystic adenomyosis: a case report and review of the literature. Australas J Ultrasound Med 22(4):295–300

    Article  PubMed  PubMed Central  Google Scholar 

  9. Dogan E, Gode F, Saatli B, Secil M (2008) Juvenile cystic adenomyosis mimicking uterine malformation: a case report. Arch Gynecol Obstet 278(6):593–595

    Article  PubMed  Google Scholar 

  10. Vlahos NF, Theodoridis TD, Partsinevelos GA (2017) Myomas and adenomyosis: impact on reproductive outcome. BioMed Res Int 2017:5926470

    Article  PubMed  PubMed Central  Google Scholar 

  11. Struble J, Reid S, Bedaiwy MA (2016) Adenomyosis: a clinical review of a challenging gynecologic condition. J Minim Invasive Gynecol 23(2):164–185

    Article  PubMed  Google Scholar 

  12. Casadio P, Raffone A, Maletta M, Travaglino A, Raimondo D, Raimondo I, Santoro A, Paradisi R, Zannoni GF, Mollo A, Seracchioli R (2021) Clinical characteristics of patients with endometrial cancer and adenomyosis. Cancers 13(19):4918

    Article  PubMed  PubMed Central  Google Scholar 

  13. Sharara FI, Kheil MH, Feki A, Rahman S, Klebanoff JS, Ayoubi JM, Moawad GN (2021) Current and prospective treatment of adenomyosis. J Clin Med 10(15):3410

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Huang R, Li X, Jiang H, Li Q (2022) Barriers to self-management of patients with adenomyosis: a qualitative study. Nurs Open 9(2):1086–1095

    Article  PubMed  Google Scholar 

  15. Kitawaki J (2006) Adenomyosis: the pathophysiology of an estrogen-dependent disease. Best Pract Res Clin Obstetr Gynaecol 20:493–502

    Article  Google Scholar 

  16. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Br Med J 339:b2700

    Article  Google Scholar 

  17. Vannuccini S, Petraglia F (2019) Recent advances in understanding and managing adenomyosis. F1000Research 8:283

    Article  Google Scholar 

  18. McCausland AM (1992) Hysteroscopic myometrial biopsy: its use in diagnosing adenomyosis and its clinical application. Am J Obstet Gynecol 166(6):1619–1628

    Article  CAS  PubMed  Google Scholar 

  19. Di Spiezio Sardo A, Calagna G, Santangelo F, Zizolfi B, Tanos V, Perino A, De Wilde RL (2017) The role of hysteroscopy in the diagnosis and treatment of adenomyosis. BioMed Res Int 2017:2518396

    Article  PubMed  PubMed Central  Google Scholar 

  20. Graziano A, Lo Monte G, Piva I, Caserta D, Karner M, Engl B, Marci R (2015) Diagnostic findings in adenomyosis: a pictorial review on the major concerns. Eur Rev Med Pharmacol Sci 19(7):1146–1154

    CAS  PubMed  Google Scholar 

  21. Dakhly D, Abdel Moety G, Saber W, Gad Allah S, Hashem A, Abdel Salam L (2016) Accuracy of hysteroscopic endomyometrial biopsy in diagnosis of adenomyosis. J Minim Invasive Gynecol 23(3):364–371

    Article  PubMed  Google Scholar 

  22. Brosens JJ, Barker FG (1995) The role of myometrial needle biopsies in the diagnosis of adenomyosis. Fertil Steril 63(6):1347–1349

    Article  CAS  PubMed  Google Scholar 

  23. Cherng-Jye J, Shih-Hung H, Jenta Sh, Chun-Shan Ch, Chii-Ruey Tz (2007) Laparoscopy-guided myometrial biopsy in the definite diagnosis of diffuse adenomyosis. Hum Reprod 22(7):2016–2019

    Article  Google Scholar 

  24. Krentel H, Cezar C, Becker S, Di Spiezio Sardo A, Tanos V, Wallwiener M, De Wilde RL (2017) From clinical symptoms to mr imaging: diagnostic steps in adenomyosis. BioMed Res Int 2017:1514029

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Di Donato N, Bertoldo V, Montanari G, Zannoni L, Caprara G, Seracchioli R (2015) Question mark form of uterus: a simple sonographic sign associated with the presence of adenomyosis. Obstet Gynecol Int 46(1):126–127

    Google Scholar 

  26. Habiba M, Benagiano G (2021) Classifying adenomyosis: progress and challenges. Int J Environ Res Public Health 18(23):12386

    Article  PubMed  PubMed Central  Google Scholar 

  27. Decter D, Arbib N, Markovitz H, Seidman DS, Eisenberg VH (2021) Sonographic signs of adenomyosis in women with endometriosis are associated with infertility. J Clin Med 10(11):2355

    Article  PubMed  PubMed Central  Google Scholar 

  28. Rasmussen CK, Hansen ES, Ernst E, Dueholm M (2019) Two- and three-dimensional transvaginal ultrasonography for diagnosis of adenomyosis of the inner myometrium. Reprod Biomed Online 38(5):750–760

    Article  PubMed  Google Scholar 

  29. Vandermeulen L, Cornelis A, Rasmussen CK, Timmerman D, van den Bosch T (2017) Guiding histological assessment of uterine lesions using 3D in vitro ultrasonography and stereotaxis. Facts Views Vision Obstetr Gynaecol 9(2):77–84

    Google Scholar 

  30. Sharma K, Bora MK, Venkatesh BP, Barman P, Roy SK, Jayagurunathan U, Sellamuthu E, Moidu F (2015) Role of 3D ultrasound and doppler in differentiating clinically suspected cases of leiomyoma and adenomyosis of uterus. J Clin Diagn Res 9(4):8–12

    Google Scholar 

  31. Săsăran V, Turdean S, Gliga M, Ilyes L, Grama O, Muntean M, Pușcașiu L (2021) Value of strain-ratio elastography in the diagnosis and differentiation of uterine fibroids and adenomyosis. J Personal Med 11(8):824

    Article  Google Scholar 

  32. Stamatopoulos CP, Mikos T, Grimbizis GF, Dimitriadis AS, Efstratiou I, Stamatopoulos P, Tarlatzis BC (2012) Value of magnetic resonance imaging in diagnosis of adenomyosis and myomas of the uterus. J Minim Invasive Gynecol 19(5):620–626

    Article  PubMed  Google Scholar 

  33. Bazot M, Cortez A, Darai E, Rouger J, Chopier J, Antoine JM, Uzan S (2001) Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology. Hum Reprod 16(11):2427–2433

    Article  CAS  PubMed  Google Scholar 

  34. Xu T, Li Y, Jiang L, Liu Q, Liu K (2022) Subserous cystic adenomyosis: a case report and review of the literature. Front Surg 9:807676

    Article  PubMed  PubMed Central  Google Scholar 

  35. Arya S, Burks HR (2021) Juvenile cystic adenomyoma, a rare diagnostic challenge: case reports and literature review. Fertil Steril Rep 2(2):166–171

    Google Scholar 

  36. Wong S, Ray CE (2022) Adenomyosis—an overview. Semin Interv Radiol 39(1):119–122

    Article  Google Scholar 

  37. Kho KA, Chen JS, Halvorson LM (2021) Diagnosis, evaluation, and treatment of adenomyosis. J Am Med Assoc 326(2):177–178

    Article  Google Scholar 

  38. Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M (2015) Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev 2015(7):CD001751

    PubMed  PubMed Central  Google Scholar 

  39. Szubert M, Koziróg E, Olszak O, Krygier-Kurz K, Kazmierczak J, Wilczynski J (2021) Adenomyosis and infertility-review of medical and surgical approaches. Int J Environ Res Public Health 18(3):1235

    Article  PubMed  PubMed Central  Google Scholar 

  40. Maia H, Maltez A, Coelho G, Athayde C, Coutinho EM (2003) Insertion of mirena after endometrial resection in patients with adenomyosis. J Am Assoc Gynecol Laparosc 10:512–516

    Article  PubMed  Google Scholar 

  41. Ozdegirmenci O, Kayikcioglu F, Akgul MA, Kaplan M, Karcaaltincaba M, Haberal A, Akyol M (2011) Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis. Fertil Steril 95:497–502

    Article  CAS  PubMed  Google Scholar 

  42. Sheng J, Zhang WY, Zhang JP, Lu D (2009) The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis. Contraception 79(3):189–193

    Article  CAS  PubMed  Google Scholar 

  43. Zhang L, Yang H, Zhang X, Chen Z (2019) Efficacy and adverse effects of levonorgestrel-releasing intrauterine system in treatment of adenomyosis. J Zhejiang Univ Med Sci 48(2):130–135

    CAS  Google Scholar 

  44. Vannuccini S, Luisi S, Tosti C, Sorbi F, Petraglia F (2018) Role of medical therapy in the management of uterine adenomyosis. Fertil Steril 109(3):398–405

    Article  PubMed  Google Scholar 

  45. Ota H, Maki M, Shidara Y, Kodama H, Takahashi H, Hayakawa M, Fujimori R, Kushima T, Ohtomo K (1992) Effects of danazol at the immunologic level in patients with adenomyosis, with special reference to autoantibodies: a multi-center cooperative study. Am J Obstet Gynecol 167(2):481–486

    Article  CAS  PubMed  Google Scholar 

  46. Igarashi M (1990) A new therapy for pelvic endometriosis and uterine adenomyosis: local effect of vaginal and intrauterine danazol application. Asia Oceania J Obstet Gynaecol 16(1):1–12

    Article  CAS  PubMed  Google Scholar 

  47. Friend DR (2017) Drug delivery for the treatment of endometriosis and uterine fibroids. Drug Deliv Transl Res 7(6):829–839

    Article  CAS  PubMed  Google Scholar 

  48. Luisi S, Razzi S, Lazzeri L, Bocchi C, Severi FM, Petraglia F (2009) Efficacy of vaginal danazol treatment in women with menorrhagia during fertile age. Fertil Steril 92(4):1351–1354

    Article  CAS  PubMed  Google Scholar 

  49. Tosti C, Vannuccini S, Troìa L, Luisi S, Centini G, Lazzeri L, Petraglia F (2017) Long-term vaginal danazol treatment in fertile age women with adenomyosis. J Endometr Pelvic Pain Adenomyosis 9(1):39–43

    Google Scholar 

  50. Yang R, Guan Y, Perrot V, Ma J, Li R (2021) Comparison of the long-acting GnRH agonist follicular protocol with the GnRH antagonist protocol in women undergoing in vitro fertilization: a systematic review and meta-analysis. Adv Ther 38(5):2027–2037

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Grow DR, Filer RB (1991) Treatment of adenomyosis with long-term GnRH analogues: a case report. Obstet Gynecol 78(3):538–539

    CAS  PubMed  Google Scholar 

  52. Donnez J, Taylor RN, Taylor HS (2017) Partial suppression of estradiol: a new strategy in endometriosis management? Fertil Steril 107(3):568–570

    Article  PubMed  Google Scholar 

  53. Taylor HS, Giudice LC, Lessey BA, Abrao MS, Kotarski J, Archer DF, Diamond MP, Surrey E, Johnson NP, Watts NB, Gallagher JC, Simon JA, Carr BR, Dmowski WP, Leyland N, Rowan JP, Duan WR, Pharm JD, Schwefel B, Thomas JW, Jain RI, Chwalisz K (2017) Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist. N Engl J Med 377:28–40

    Article  CAS  PubMed  Google Scholar 

  54. Kimura F, Takahashi K, Takebayashi K, Fujiwara M, Kita N, Noda Y, Harada N (2007) Concomitant treatment of severe uterine adenomyosis in a premenopausal woman with an aromatase inhibitor and a gonadotropin-releasing hormone agonist. Fertil Steril 87(6):e9–e12

    Article  Google Scholar 

  55. Shrestha A, Shrestha R, Sedhai LB, Pandit U (2012) Adenomyosis at hysterectomy: prevalence, patient characteristics, clinical profile and histopathological findings. Kathmandu Univ Med J 10(37):53–56

    CAS  Google Scholar 

  56. Stovall TG, Summitt RL (1996) Laparoscopic hysterectomy—is there a benefit? N Engl J Med 335(7):512–513

    Article  CAS  PubMed  Google Scholar 

  57. Munro MG (2018) Endometrial ablation. Best practice and research. Clin Obstet Gynaecol 46:120–139

    Google Scholar 

  58. McCausland V, McCausland A (1998) The response of adenomyosis to endometrial ablation/resection. Hum Reprod Update 4(4):350–359

    Article  CAS  PubMed  Google Scholar 

  59. Dueholm M (2018) Minimally invasive treatment of adenomyosis. Best practice and research. Clin Obstet Gynaecol 51:119–137

    Google Scholar 

  60. de Bruijn A, Smink M, Hehenkamp W, Nijenhuis RJ, Smeets AJ, Boekkooi F, Reuwer P, van Rooij WJ, Lohle P (2017) Uterine artery embolization for symptomatic adenomyosis: 7-year clinical follow-up using UFS-Ool questionnaire. Cardiovasc Intervent Radiol 40(9):1344–1350

    Article  PubMed  PubMed Central  Google Scholar 

  61. Wang P, Liu WM, Fuh JL, Cheng MH, Chao HT (2009) Comparison of surgery alone and combined surgical-medical treatment in the management of symptomatic uterine adenomyoma. Fertil Steril 92(3):876–885

    Article  CAS  PubMed  Google Scholar 

  62. Taran FA, Stewart EA, Brucker S (2013) Adenomyosis: epidemiology, risk factors, clinical phenotype and surgical and interventional alternatives to hysterectomy. Geburtshilfe Frauenheilkd 73(9):924–931

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Wood C, Maher P, Hill D (1994) Biopsy diagnosis and conservative surgical treatment of adenomyosis. J Am Assoc Gynecol Laparosc 1(4):313–316

    Article  CAS  PubMed  Google Scholar 

  64. Nishida M, Takano K, Arai Y, Ozone H, Ichikawa R (2010) Conservative surgical management for diffuse uterine adenomyosis. Fertil Steril 94(2):715–719

    Article  PubMed  Google Scholar 

  65. Gao Y, Shan S, Zhao X, Jiang J, Li D, Shi B (2019) Clinical efficacy of adenomyomectomy using “H” type incision combined with Mirena in the treatment of adenomyosis. Medicine 98(11):e14579

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Nishida M, Ichikawa R, Arai Y, Sakanaka M, Otsubo Y (2014) New myomectomy technique for diffuse uterine leiomyomatosis. J Obstet Gynaecol Res 40(6):1689–1694

    Article  PubMed  Google Scholar 

  67. Cheung VY (2017) Current status of high-intensity focused ultrasound for the management of uterine adenomyosis. Ultrasonography 36(2):95–102

    Article  PubMed  Google Scholar 

  68. Fukunishi H, Funaki K, Sawada K, Yamaguchi K, Maeda T, Kaji Y (2008) Early results of magnetic resonance-guided focused ultrasound surgery of adenomyosis: analysis of 20 cases. J Minim Invasive Gynecol 15(5):571–579

    Article  PubMed  Google Scholar 

  69. Shui L, Mao S, Wu Q, Huang G, Wang J, Zhang R, Li K, He J, Zhang L (2015) High-intensity focused ultrasound (HIFU) for adenomyosis: two-year follow-up results. Ultrason Sonochem 27:677–681

    Article  CAS  PubMed  Google Scholar 

  70. Kowalik A, Zalewski K, Kopczynski J, Siolek M, Lech M, Hincza K, Kalisz J, Chrapek M, Zieba S, Furmanczyk O, Jedlinski M, Chlopek M, Misiek M, Gozdz S (2019) Somatic mutations in BRCA1 and 2 in 201 unselected ovarian carcinoma samples - single institution study. Polish J of Pathol 70(2):115–126

    Article  Google Scholar 

Download references

Funding

The author declares that no funds, grants, or other support were received during the preparation of this manuscript.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Pavlodar Branch of the Semey Medical University, 72/1 Toraigyrov Str., 140002, Pavlodar, Republic of Kazakhstan

    Rymgul S. Moldassarina

Authors
  1. Rymgul S. Moldassarina
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

RSM: project development, data collection, manuscript writing.

Corresponding author

Correspondence to Rymgul S. Moldassarina.

Ethics declarations

Conflict of interest

The author has no relevant financial or non-financial interests to disclose.

IRB ethical approval

This study did not require ethics approval, since the research does not involve human participants and/or animals.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moldassarina, R.S. Modern view on the diagnostics and treatment of adenomyosis. Arch Gynecol Obstet 308, 171–181 (2023). https://doi.org/10.1007/s00404-023-06982-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-023-06982-1

Keywords

Search

Navigation